Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
rYojbaba Announces Participation in the Guardian Girls Aikido Project in Los Angeles, CA
-
Plexus to Present at the Raymond James 47th Annual Institutional Investors Conference
-
K Wave Media Regains Compliance with Nasdaq Minimum Market Value Requirement
-
ToltIQ and Intapp Partner to Unify Deal Execution and Due Diligence for Private Markets Firms
-
Xanadu Nominates Experienced Global Business Leaders to its Board of Directors
-
Nexalin Participates in and Commends Recent Congressional Momentum Supporting Deep Brain Neurostimulation Research for Veterans and Neurological Disorders
-
Lead Real Estate Co., Ltd Announces Completion of NAOI STYLE NAKAMEGURO YUTENJI 1-CHOME Single-Family Home in Tokyo
-
Thirteen Industry Leaders Unite to Define Active Copper Cable Standards
-
Ocean Power Technologies Provides Operational Update on Global Deployments and Infrastructure Development
-
Compass Diversified Announces Appointment of Eric Weis as President of PrimaLoft; Elevation of Shawn Neville to PrimaLoft Board Chair
-
Transactions in connection with share buyback programme
-
Safe Pro Group Projects Over 500% Year-Over-Year Q1 2026 Revenue Growth Following U.S. Government Award for AI Edge Processing Systems
-
Johnson Fistel Investigates the Grindr Board for Potential Breaches of Fiduciary Duties Relating to the Grindr Buyout Termination
-
Celldex Announces Multiple Upcoming Presentations at AAAAI 2026 Supporting Barzolvolimab’s First-in-Class and Best-in-Disease Profile
-
CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference
-
Geron Plans to Present at Upcoming Investor Conferences
-
Beyond Oil Announces Meeting of Shareholders
-
FTC Solar Announces Supply Agreement with Lubanzi Inala
-
Axonius Federal Systems Names Jared Vichengrad Senior Vice President and General Manager Following Record Federal Results
-
Seismic Therapeutic to Participate in Upcoming Investor Conferences
-
Daré Bioscience Announces FDA Clearance of IND for Phase 2 Clinical Study of DARE-HPV, a Potential Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer
-
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on March 4
-
LifeMD to Report Fourth Quarter 2025 Financial Results on March 9
-
Beacon Therapeutics to Participate in TD Cowen's 46th Annual Health Care Conference
-
MBX Biosciences to Participate in Upcoming March Investor Conferences
-
BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day
-
Precise Bio Announces Successful Transplantation of Additional Patients in Ongoing Clinical Study of 3D-Bio-Printed Corneal Implant
-
MKS Inc. to Participate in Morgan Stanley’s Technology, Media & Telecom Conference
-
Leading Heart Transplant Centers Convene in Houston for Picard Medical/ SynCardia’s Total Artificial Heart Surgical Training
-
Pelthos Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
-
Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference
-
Lyell Immunopharma Announces Participation in March Investor Conferences
-
LYB announces updated 2030 sustainability goals
-
Corporate Debt and Equity CUSIP Request Volumes Increase in January
-
Ascentage Pharma to Participate in Three Upcoming Investor Conferences
-
TOP Ships Inc. Announces Agreement to Acquire Nine ECO MR Product Tanker Newbuildings with Time Charter Employment and Potential Gross Revenue Backlog of about $679 million
-
Belite Bio to Host Webcast on March 2, 2026, to Discuss Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
-
Getty Images and Shutterstock Receive Unconditional Antitrust Clearance from U.S. Department of Justice for Proposed Merger
-
B2Gold Announces Leadership Transition
-
ARRAY Technologies to Participate in Upcoming Conference for the Investor Community
-
Recursion To Be Featured in HighRes’ Lightning Talk at NVIDIA GTC
-
Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease
-
Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol
-
Milemarker Appoints Adrienne Paulsen as Vice President of Operations
-
The Oncology Institute Appoints Kim Tzoumakas to Board of Directors
-
NodThera to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
-
Lincoln Educational Services’ Fourth Quarter and Full Year 2025 Results Exceed Financial Guidance; Continued Strong Growth Forecasted for 2026
-
VFN Holdings, Inc. (Vero Networks) Announces $500 Million Strategic Investment by Hamilton Lane, Braemont Capital and Delta-v Capital
-
This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease
-
Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress

